First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer

PURPOSE: Prospectively collected outcome data of patients (pts) whose adjuvant systemic therapy recommendation was based on the clinico-molecular test EndoPredict(®) (EP) are presented. METHODS: Pts with ER-positive, HER2-negative early breast cancer with 0–3 positive lymph nodes were enrolled. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettl, Johannes, Anders, Sophie-Isabelle, Hapfelmeier, Alexander, Paepke, Stefan, Noske, Aurelia, Weichert, Wilko, Klein, Evelyn, Kiechle, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584549/
https://www.ncbi.nlm.nih.gov/pubmed/32902674
http://dx.doi.org/10.1007/s00404-020-05771-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584549/
https://www.ncbi.nlm.nih.gov/pubmed/32902674
http://dx.doi.org/10.1007/s00404-020-05771-4

Ejemplares similares